Aaron Betz, PA-C in Delta, OH - Physician Assistant

Aaron Betz, PA-C is a Physician Assistant based in Delta, Ohio. Aaron Betz is licensed to practice in Ohio (license number 1171406) and his current practice location is 7970 County Road 5 2, Delta, Ohio. He can be reached at his office (for appointments etc.) via phone at (419) 376-7428.

NPI number for Aaron Betz is 1477314466 and his current mailing address is 7970 County Road 5 2, Delta, Ohio. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1477314466.

Contact Information

	Aaron Betz, PA-C
	7970 County Road 5 2, Delta, OH 43515-9722
	(419) 376-7428
	Not Available

Provider's Profile

Full Name	Aaron Betz
Gender	Male
Speciality	Physician Assistant
Location	7970 County Road 5 2, Delta, Ohio
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1477314466
Provider Enumeration Date: 01/17/2024
Last Update Date: 01/17/2024

Medical Identifiers

Medical identifiers for Aaron Betz such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1477314466	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
363A00000X	Physician Assistant	1171406 (Ohio)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Aaron Betz is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Aaron Betz, PA-C 7970 County Road 5 2, Delta, OH 43515-9722 Ph: (419) 376-7428	Aaron Betz, PA-C 7970 County Road 5 2, Delta, OH 43515-9722 Ph: (419) 376-7428

News Archive

"Misreading" of histone code linked to human cancer

The development of blood from stem cell to fully formed blood cell follows a genetically determined program. When it works properly, blood formation stops when it reaches maturity. But when it doesn't, genetic mutations can prevent the stop signal and cause the developing cells to turn cancerous. In research published in Nature, Rockefeller University scientists show for the first time that a misreading of the blood cells' histone code is responsible for acute myeloid leukemia, a rare form of the deadly blood cancer.

LimTox online software tool provides information on drug hepatotoxicity

The Biological Text Mining Unit presents in a recent Nucleic Acids Research paper the LimTox online software tool developed at the Spanish National Cancer Research Centre.

Study: Administration of endocrine disruptor causes epigenetic changes in pregnant sow's DNA

The public debate on endocrine disrupting chemicals- exogenous substances that have the same or similar effects as endogenous hormones - has been going on for some time.

Longer looks: Understanding the mind; facebook depression; planning for a successful end of life

Every week reporter Ankita Rao selects interesting reading from around the Web.

DATATRAK signs agreement for three new Phase III oncology studies

DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the signing of an Enterprise Agreement for three new Phase III oncology studies with an existing client. These multi-center studies will be deployed utilizing the unified DATATRAK eClinical™ platform.

Aaron Betz, PA-C - Physician Assistant in Delta, OH